Intco Medical Technology Co Sustainability Profile
Intco Medical Technology Co., Ltd., commonly referred to as Intco Medical, is a leading player in the medical supplies industry, headquartered in China. Established in 1993, the company has expanded its operations across various regions, including North America, Europe, and Asia, solidifying its global presence. Specialising in disposable medical products, Intco Medical is renowned for its high-quality offerings, including gloves, wound care supplies, and rehabilitation equipment. The company’s commitment to innovation and quality has earned it a strong market position, with notable achievements in product development and customer satisfaction. With a focus on enhancing healthcare standards, Intco Medical continues to set benchmarks in the industry, making it a trusted name among healthcare professionals worldwide.
DitchCarbon Score
How does Intco Medical Technology Co's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Intco Medical Technology Co's score of 27 is lower than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Intco Medical Technology Co's reported carbon emissions
In 2023, Intco Medical Technology Co., headquartered in China (CN), reported significant carbon emissions, totalling approximately 1,409,300,000 kg CO2e for Scope 1 and about 290,800,000 kg CO2e for Scope 2. This reflects a notable increase from 2022, where emissions were around 1,045,500,000 kg CO2e for Scope 1 and 178,900,000 kg CO2e for Scope 2. The company has not disclosed any Scope 3 emissions data. Intco Medical has committed to a long-term sustainability roadmap, aiming to peak its carbon emissions by 2029 and achieve full carbon neutrality by 2050. This commitment encompasses both Scope 1 and Scope 2 emissions, indicating a strategic focus on reducing direct and indirect emissions associated with its operations. The company’s emissions data is self-reported and does not appear to be cascaded from any parent organisation. As part of its climate strategy, Intco Medical is actively working towards its reduction targets, aligning with industry standards for climate action.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 988,700,000 | 0,000,000,000 | 0,000,000,000 |
| Scope 2 | 239,800,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - |
How Carbon Intensive is Intco Medical Technology Co's Industry?
How Carbon Intensive is Intco Medical Technology Co's Location?
Intco Medical Technology Co's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Intco Medical Technology Co has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
